Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × COVID-19 × High-Throughput Nucleotide Sequencing × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 5 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Recurrence 2 Breast Neoplasms 2 Stage IIIb and IV Non Small Cell Lung Cancer 1 Solid Tumor, Adult 1 Rare Diseases 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplastic Syndromes, Hereditary 1 Neoplasm, Residual 1 Multiple Myeloma 1 Mouth Neoplasms 1 Microsatellite Instability 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Head and Neck Neoplasms 1 Genetic Predisposition to Disease 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Medullary 1 COVID-19 1 Biliary Tract Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Blood Specimen Collection 6 Surveys and Questionnaires 5 Standard of Care 5 BNT162 Vaccine 5 Surgical Procedures, Operative 3 Specimen Handling 3 Practice Guidelines as Topic 3 Hydroxychloroquine 3 COVID-19 Vaccines 3 2019-nCoV Vaccine mRNA-1273 3 tocilizumab 2 sotrovimab 2 Pandemic Preparedness 2 CVnCoV COVID-19 vaccine 2 Azithromycin 2 sinovac COVID-19 vaccine 1 selinexor 1 remdesivir 1 ogalvibart 1 monalizumab 1 lenzilumab 1 heterologous prime boost COVID-19 vaccination 1 crexavibart 1 cilgavimab and tixagevimab drug combination 1 ciclesonide 1 avdoralimab 1 XAV-19 1 Therapeutics 1 Telemedicine 1 Sperm Count 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04345315 2020-04-15

CORSA

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡